Glatiramer Subcutaneous and NovoLog FlexPen
Determining the interaction of Glatiramer Subcutaneous and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Novolog Injection
- Glatiramer Subcutaneous-NovoLog Mix 70/30
- Glatiramer Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Glatiramer Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Glatiramer Subcutaneous-NovoLog Mix 70/30 FlexPen
- Glatiramer Subcutaneous-NovoLog PenFill
- NovoLog FlexPen-Glatopa
- NovoLog FlexPen-Glatopa injection
- NovoLog FlexPen-Glecaprevir and pibrentasvir
- NovoLog FlexPen-Gleevec
- NovoLog FlexPen-Glenmax PEB DM
- NovoLog FlexPen-Glenmax PEB DM FORTE